Feed - Buzzberg

12:00
Jul 29 ◎

HUM FY2026 Q2 Watch

Humana Inc. (HUM) FY2026 Q2 Earnings Call

ANTHROPIC UHG EHC HUM ▾

Jim Rechtin

Hiring a senior Anthropic executive to the board signals Humana's intent to leverage AI and Anthropic's models in its operations.

"Paul is the Chief Commercial Officer at Anthropic, where he leads commercial strategy and global go-to-market operations."

ANTHROPIC WATCH

Jim Rechtin

Humana is centralizing 11 markets' utilization management into one team, a step beyond simple vendor consolidation, indicating deep operational restructuring. — This is a permanent reduction in medical management scope, which could pressure managed care vendors providing UM services.

"One example is utilization management, where we centralized 11 markets into one team."

UHG WATCH

Celeste Mellet

Inpatient favorability is concentrated in members engaged with value-based providers, which limits the financial benefit passing through to Humana but validates the VBC model. — While positive for provider partners, Humana's profit growth is constrained by this mix, suggesting a slower margin recovery than headline numbers imply.

"favorability has been more heavily concentrated in members engaged with value-based providers."

EHC WATCH

Jim Rechtin

Management reiterated confidence in achieving its 2028 margin target of at least 3%, with meaningful progress expected in 2027, driven by cost actions and bidding strategy. The tone is cautiously optimistic with a focus on execution.

"We expect that our approach to 2027 is will drive solid progress against our goal of delivering a sustainable pre-tax margin of at least 3% in 2028."

HUM WATCH

HIGH

12:00
Apr 29 ◎

HUM FY2026 Q1 Watch

Humana Inc. (HUM) FY2026 Q1 Earnings Call

HUM UNH CVS ▾

Jim Recton

Management is confidently reiterating its commitment to reach at least 3% MA margin in 2028, emphasizing progress on cost transformation and operational efficiency. They indicate that benefit adjustments for 2027 are necessary to bridge the funding gap versus medical cost trend, framing this as a disciplined step towards the long-term target.

"we are pleased with the solid start to 2026 and believe our expanded membership base, relentless focus on returning to top quartile stars, and pricing discipline position us well to deliver a stable and compelling MA margin and unlock the"

HUM WATCH

Jim Recton

Humana is preparing for the 2027 bid with a need for larger benefit cuts than the prior year, explicitly stating the 'gap between funding and medical cost trend is larger going into this bid season than it was a year ago.' This indicates a worsening funding environment for the Medicare Advantage industry as a whole. — This signals a potential industry-wide struggle to maintain margins and could lead to more aggressive benefit cuts or premium increases across the sector, potentially impacting membership growth and valuation multiples for competitors like UNH and CVS.

"the gap between funding and medical cost trend is larger going into this bid season than it was a year ago. It's very clearly larger than it was a year ago."

UNH WATCH CVS WATCH

HIGH

13:00
Feb 11 ◎

HUM FY2025 Q4 Watch

Humana Inc. (HUM) FY2025 Q4 Earnings Call

HUM UNH CVS ▾

Celeste Millay

Guidance points to a significant decline in EPS for 2026, driven by the large STARS headwind and slightly negative individual MA margins, though management emphasizes a doubling of margins when normalizing for STARS and sees growth as accretive to the enterprise.

"We expect full-year adjusted EPS of at least $9. With the anticipated year-over-year decline driven by the previously communicated bonus year 2026 STARS headwind net of mitigation, we remain confident in the overall assumptions used in our"

HUM WATCH

Jim Recton

Humana gained ~1 million net new MA members (20% AEP growth) with a 500 bps retention improvement; 70% of new sales were switchers from competitors, but Humana only absorbed 12% of competitor plan-exit members — less than its market share, implying rivals retained more of their exiting members or other competitors captured a larger share. — This suggests competitor plan exits (e.g., from UNH or CVS) may have driven less churn benefit to Humana than its market share would imply, potentially indicating those competitors found ways to retain more of their exiting members or other rivals captured more.

"We did not have a high percentage of members impacted by competitor plan exits. we absorbed approximately 12% of these members. That is notably less than our market share."

UNH WATCH CVS WATCH

HIGH

Feed — Buzzberg